On the contrary, decreased TMEM219 expression was observed in lung squamous cell carcinoma (log2 fold change −0.74), stomach adenocarcinoma (log2 fold change −0.42), colon adenocarcinoma (log2 fold change −0.36), head and neck squamous cell carcinoma (log2 fold change −0.32), lung adenocarcinoma (log2 fold change −0.12), and kidney chromophobe (log2 fold change −0.10). The gene discussed is TMEM219; the disease is head and neck squamous cell carcinoma.